GA NCORP

Doctors

Barry D. Luskey MD

Summit Cancer Care
www.summitcancercare.com

Education & Training

Medical School: University of Texas Southwestern Medical, Dallas, Texas

Internship: Brigham & Women's Hospital, Boston, Massachusetts

Residency: Brigham & Women's Hospital, Boston, Massachusetts

Fellowship: Brigham & Women's Hospital, Boston, Massachusetts, The Children's Hospital, Boston, Massachusetts

Specialty and Certification

Medical Oncology, Hematology / Board Certified

Clinical Trial Cancer Types

Cervical Cancer, Colon/Rectal Cancer, COVID-19, Esophogeal Cancer, Hematopoietic Malignancies, Leukemia, Lung Cancer, Multiple Myeloma, Non-Hodgkin Lymphoma, Pancreatic Cancer, Plasma cell neoplasm, Prostate Cancer , Solid Tumor

Affliations

St. Joseph's/Candler

Active Clinical Trial Sites


Nancy N. and J.C. Lewis Cancer Research Pavilion at St. Joseph Candler

225 Candler Drive
Savannah, GA 31405
912-819-5704 (p)
www.sjchs.org

driving directions

Clinical Trials

BRAF V600E-mutant Colorectal Cancer Study of Encorafenib Taken With Cetuximab Plus or Minus Chemotherapy (BREAKWATER)
Cancer Type: Colon/Rectal Cancer

NCI COVID-19 in Cancer Patients, NCCAPS Study
Cancer Type: COVID-19

Nivolumab and Ipilimumab in Treating Patients with Esophageal and Gastroesophageal Junction Adenocarcinoma Undergoing Surgery
Cancer Type: Esophogeal Cancer

NCI COVID-19 in Cancer Patients, NCCAPS Study
Cancer Type: Hematopoietic Malignancies

Testing The Addition of a New Anti-cancer Drug, Venetoclax, to the Usual Treatment (Ibrutinib and Obinutuzumab) in Untreated, Older Patients with Chronic Lymphocytic Leukemia
Cancer Type: Leukemia

Chemoradiation with or without Atezolizumab in Treating Patients with Limited Stage Small Cell Lung Cancer
Cancer Type: Lung Cancer

TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Cancer Type: Multiple Myeloma

Testing the Addition of Daratumumab-Hyaluronidase to Enhance Therapeutic Effectiveness of Lenalidomide in Smoldering Multiple Myeloma, The DETER-SMM Trial
Cancer Type: Multiple Myeloma

TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Cancer Type: Non-Hodgkin Lymphoma

Comparing Two Treatment Combinations, Gemcitabine and Nab-Paclitaxel with 5-Fluorouracil, Leucovorin, and Liposomal Irinotecan for Older Patients with Pancreatic Cancer That Has Spread
Cancer Type: Pancreatic Cancer

TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Cancer Type: Plasma cell neoplasm

Antiandrogen Therapy and Radiation Therapy with or without Docetaxel in Treating Patients with Prostate Cancer That Has Been Removed by Surgery
Cancer Type: Prostate Cancer

CASPAR, A Clinical Study Evaluating The Benefit of Adding Rucaparib to Enzalutamide for Men with Metastatic Prostate Cancer That Has Become Resistant To Testosterone-Deprivation Therapy
Cancer Type: Prostate Cancer

NCI COVID-19 in Cancer Patients, NCCAPS Study
Cancer Type: Solid Tumor

Antiandrogen Therapy and Radiation Therapy with or without Docetaxel in Treating Patients with Prostate Cancer That Has Been Removed by Surgery
Cancer Type: Unknown Primary

Comparing Two Treatment Combinations, Gemcitabine and Nab-Paclitaxel with 5-Fluorouracil, Leucovorin, and Liposomal Irinotecan for Older Patients with Pancreatic Cancer That Has Spread
Cancer Type: Unknown Primary

CASPAR, A Clinical Study Evaluating The Benefit of Adding Rucaparib to Enzalutamide for Men with Metastatic Prostate Cancer That Has Become Resistant To Testosterone-Deprivation Therapy
Cancer Type: Unknown Primary

Summit Cancer Care - Statesboro

16741 Highway 67 South
Suite B
Statesboro, GA 30458
912-871-8837 (p)
www.summitcancercare.com

driving directions

 
For a complete listing of all trial sites in Georgia, please visit GeorgiaCancerInfo.org